Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

Informations

Home » Informations
  • Shaping the Future of AI in GI Care – Dr. Shahnaz Sultan’s Leadership in the 2025 AGA Guideline

    Dr. Shahnaz Sultan led the multidisciplinary panel behind the AGA Living Clinical Practice Guideline on Computer-Aided Detection–Assisted Colonoscopy, published in April 2025 in Gastroenterology.This guideline addresses one of the most…

    2025.04.18
  • Trastuzumab Deruxtecan Shows Intracranial Activity in HER2-Positive Breast Cancer with Active Brain Metastases

    A patient-level pooled analysis combining the DEBBRAH and TUXEDO-1 trials along with the DFCI/Duke/MDACC cohort, published in ESMO Open (January 3, 2025), demonstrated clinically meaningful intracranial efficacy of trastuzumab deruxtecan…

    2025.04.18
  • Blood Science Update| MicroRNAs: Discovery, Breakthrough, and Innovation

    Historical Foundations and Discovery The origins of miRNA research trace back to the early 1990s, when Ambros and Ruvkun, both postdoctoral fellows in H. Robert Horvitz’s laboratory at MIT, investigated…

    2025.04.17
  • Blood Science Update| Mitochondrial Genetic Variations in Leukemia: A Comprehensive Overview

    Mitochondrial Genetics: A Distinct Layer of Complexity Mitochondria, as essential energy-generating organelles, possess a compact 16.5 kb circular genome encoding 37 genes critical for oxidative phosphorylation. Unlike nuclear DNA, mtDNA…

    2025.04.17
  • Blood Science Update |Pre-Transplantation KMT2A-PTD Levels Predict Relapse in AML After Haploidentical HSCT

    Study Design and Methods This single-center retrospective study analyzed 64 AML patients with KMT2A-PTD positivity at diagnosis who underwent HID HSCT between April 2016 and December 2020. Based on their…

    2025.04.17
  • Blood Science Update|γδ T Cells in Hematological Malignancies: Mechanisms and Therapeutic Strategies

    Study Focus and Methods The authors conducted a comprehensive synthesis of existing literature, experimental data, and ongoing clinical trials to evaluate the roles of γδ T cell subsets in antitumor…

    2025.04.17
  • CUDA Yanqi Lake Meeting | Prof. Nianzeng Xing: Advancing Urology in China Through Multidisciplinary Collaboration

    From April 11 to 13, 2025, the 5th Chinese Urological Doctor Association Yanqi Lake Meeting—jointly organized by the Chinese Medical Doctor Association and Chinese Urological Doctor Association—was successfully held in Beijing. The event brought together prominent experts from across the country to explore the future of urology in China. UroStream invited Professor Nianzeng Xing, President…

    2025.04.17
  • Blood Science Update|In Vitro Erythropoiesis: The Emerging Potential of Induced Pluripotent Stem Cells (iPSCs)

    Despite over 100 million units of blood being donated annually, supply remains insufficient, particularly for patients with chronic conditions or in crisis settings. Alloimmunization and blood group incompatibilities further constrain transfusion efficacy. In response, researchers are exploring the use of induced pluripotent stem cells (iPSCs) to generate red blood cells (RBCs) in vitro as a…

    2025.04.17
«previous next»
Recent Posts
  • Professor Xinan Sheng: Advancing ADC Sequencing Strategies to Overcome Drug Resistance
  • Advancing Precision Therapy in Urothelial Carcinoma: A Collaborative Study by Professors Xuesong Li, Qi Tang, Jianhua Zhang, and Xiaoying Li Explores a Novel Approach to HER2 Assessment
  • Disitamab Vedotin–Based Combination Strategy Redefines First-Line Treatment for Advanced Urothelial Carcinoma, Nearly Doubling Overall Survival
  • 2025 Tianjin International Breast Cancer Conference | Prof. Jihui Hao: A Blueprint for Intelligent Breast Cancer Prevention and Care
  • 2025 Tianjin International Breast Cancer Conference | Prof. Zhongsheng Tong: Targeted Therapy Frontiers and the “Tianjin Experience”
Recent Comments
    Archives
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Paris, France
    Scroll to Top